Cargando…

Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines

Lipid nanoparticles (LNPs) are widely used as delivery systems for mRNA vaccines. The stability and bilayer fluidity of LNPs are determined by the properties and contents of the various lipids used in the formulation system, and the delivery efficiency of LNPs largely depends on the lipid compositio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xiaojuan, Yu, Chuanfei, Wu, Xiaohong, Cui, Yu, Liu, Xiaoda, Jin, Yan, Li, Yuhua, Wang, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222414/ https://www.ncbi.nlm.nih.gov/pubmed/37243041 http://dx.doi.org/10.3390/vaccines11050937

Ejemplares similares

Thermotropic effects of PEGylated lipids on the stability of HPPH-encapsulated lipid nanoparticles (LNP)
por: Kalyanram, Poornima, et al.
Publicado: (2021)

Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
por: Liu, Cong, et al.
Publicado: (2022)

Ionizable Lipids with Triazole Moiety from Click Reaction for LNP-Based mRNA Delivery
por: Wang, Yixiang, et al.
Publicado: (2023)

The effects of PEGylation on LNP based mRNA delivery to the eye
por: Ryals, Renee C., et al.
Publicado: (2020)

The mRNA-LNP platform’s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
por: Ndeupen, Sonia, et al.
Publicado: (2021)

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
por: Ndeupen, Sonia, et al.
Publicado: (2021)

Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans
por: Moyles, Iain R., et al.
Publicado: (2023)

Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety
por: Vlatkovic, Irena
Publicado: (2021)

Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects
por: Kiaie, Seyed Hossein, et al.
Publicado: (2022)

Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species
por: Peng, Lei, et al.
Publicado: (2022)

Optimal self-assembly of lipid nanoparticles (LNP) in a ring micromixer
por: Ripoll, Manon, et al.
Publicado: (2022)

Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines
por: Somiya, Masaharu, et al.
Publicado: (2021)

An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
por: Ripoll, Manon, et al.
Publicado: (2022)

Evaluation of the Saponin Content in Panax vietnamensis Acclimatized to Lam Dong Province by HPLC–UV/CAD
por: Nguyen, Huy Truong, et al.
Publicado: (2021)

Could amantadine interfere with COVID-19 vaccines based on the LNP-mRNA platform?
por: Fedorowski, Jaroslaw J.
Publicado: (2021)

Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells
por: Maugeri, Marco, et al.
Publicado: (2019)

Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines
por: Tsiambas, Evangelos, et al.
Publicado: (2021)

An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization
por: Hsu, Fu-Fei, et al.
Publicado: (2022)

mRNA-LNP vaccination-based immunotherapy augments CD8(+) T cell responses against HPV-positive oropharyngeal cancer
por: Qiu, Ke, et al.
Publicado: (2023)

Induction of Protective Immunity against Toxoplasma gondii in Mice by Nucleoside Triphosphate Hydrolase-II (NTPase-II) Self-amplifying RNA Vaccine Encapsulated in Lipid Nanoparticle (LNP)
por: Luo, Fangjun, et al.
Publicado: (2017)

Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice
por: Zhang, Mengling, et al.
Publicado: (2020)

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
por: Granados-Riveron, Javier T., et al.
Publicado: (2021)

Single-cell suspension preparation from murine organs following in vivo mRNA-LNP exposure
por: Ndeupen, Sonia, et al.
Publicado: (2022)

Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability
por: Zhang, Lizhou, et al.
Publicado: (2023)

Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection
por: Baldeon Vaca, Gabriela, et al.
Publicado: (2023)

Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines
por: Patel, Nisarg, et al.
Publicado: (2023)

Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB/c mice against acute toxoplasmosis
por: Zhang, Yizhuo, et al.
Publicado: (2023)

Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
por: Connors, Jennifer, et al.
Publicado: (2022)

Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
por: Connors, Jennifer, et al.
Publicado: (2023)

Formulation of Lipid-Free Polymeric Mesoscale Nanoparticles Encapsulating mRNA
por: Skelton, Rachel, et al.
Publicado: (2022)

mRNA-Lipid Nanoparticle (LNP) Delivery of Humanized EpCAM-CD3 Bispecific Antibody Significantly Blocks Colorectal Cancer Tumor Growth
por: Golubovskaya, Vita, et al.
Publicado: (2023)

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice
por: Kenjo, Eriya, et al.
Publicado: (2021)

Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
por: Valentin, Antonio, et al.
Publicado: (2022)

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
por: Daly, Owen, et al.
Publicado: (2023)

Hybrid LNP Prime Dendritic Cells for Nucleotide Delivery
por: Das, Riddha, et al.
Publicado: (2023)

Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion
por: Qin, Zhen, et al.
Publicado: (2022)

Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion
por: Qin, Zhen, et al.
Publicado: (2022)

mRNA-LNP vaccines tuned for systemic immunization induce strong antitumor immunity by engaging splenic immune cells
por: Bevers, Sanne, et al.
Publicado: (2022)

mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
por: Hayashi, Clifford T. H., et al.
Publicado: (2022)

Cationic LNP-formulated mRNA expressing Tie2-agonist in the lung endothelium prevents pulmonary vascular leakage
por: Radloff, Katrin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91s3j4aer6pu053lnirjil8lbu